Study: How to Prevent Genital Herpes Transmission; polyDNA recommends Targeting the Latent HSV with Gene-Eden-VIR

Share Article

A treatment or intervention that maintains genital viral load below a threshold of 10,000 copies of herpes simplex DNA would prevent most transmissions of genital herpes, according to a study published on March 26, 2014 in The Journal of the Royal Society Interface (1). polyDNA reviews the report and recommends that individuals speak to their doctors about Gene-Eden-VIR.

News Image
We recommend using Gene-Eden-VIR to help the immune system target the latent HSV-2. - Mike Evans, polyDNA

A new study found that preventing the transmission of genital herpes can be accomplished by decreasing the HSV DNA viral load below 10,000 copies (1). The researchers discovered that high numbers of HSV copies in the genital tract, immediately before a person has sex, increases the probability of transmission. As study authors wrote “…viral quantity at coitus (during sex) is likely to predict the probability of a virus contacting and engaging receptors on susceptible cells (entering a cell) in the uninfected partner’s genital tract (1). In addition, “It is highly likely that viral load has at least a partially predictive relationship on probability of transmission (1).” polyDNA therefore recommends that individuals infected with the herpes virus speak to their doctors about Gene-Eden-VIR. This natural product designed to help the immune system target the latent HSV-2.

Dr. Joshua T. Schiffer said “Herpes simplex virus 2 (HSV-2) expands very rapidly, from zero to tens of millions, often in 24 hours.” (See, from March 26, 2014) (2). “Most of the time, the virus is cleared quickly enough so that an infected person is not even aware that the virus is reactivating,” he continued. “But there's still enough time to transmit it to a partner (2).”

“HSV-2 is spread through oral, vaginal or anal sex. The Centers for Disease Control estimates that one out of every six people in the United States between the ages of 14 and 49 has genital herpes, with 776,000 people newly infected each year (2).”

Preventing transmission is critical because there is no cure for herpes. There are treatments and natural remedies, however. “Two types of antiviral treatments against HSV are available: topical and oral. The treatments include penciclovir, acyclovir, famciclovir, and valaciclovir. However, their effectiveness is limited. For instance, a meta-analysis of five placebo-controlled and two dose comparison studies evaluated the effect of aciclovir, famciclovir or valaciclovir on symptoms. The meta-analysis showed that oral antiviral therapy decreases the duration and the associated pain of an outbreak by merely one day.” (See Pharmacology & Pharmacy, from September 2013) (3). Gene-Eden-VIR is a natural antiviral that was proven to reduce symptoms of genital herpes infections in a post-marketing clinical study that followed FDA guidelines.

“We recommend using Gene-Eden-VIR to help the immune system target the latent HSV-2.” - Mike Evans, polyDNA

A study published on August 12, 2013 in the peer reviewed, medical journal Pharmacology & Pharmacy, in a special edition on Advances in Antiviral Drugs, showed that Gene-Eden-VIR reduced herpes symptoms. Study authors wrote that, “Individuals infected with the herpes virus… reported a safe decrease in their symptoms following treatment with Gene-Eden-VIR (3).” The study authors also wrote that, “We observed a statistically significant decrease in the severity, duration, and frequency of symptoms (3).”

Research shows that an infection with one of the viruses above causes a feeling of physical and mental fatigue. Since Gene-Eden-VIR is antiviral, a second post-marketing clinical study showed that Gene-Eden-VIR decreases the feeling of physical and mental fatigue. That study was published in March, 2014 in the journal Pharmacology & Pharmacy (4).

To read the study on the antiviral nature of Gene-Eden-VIR, visit:

To read the study on Gene-Eden-VIR’s effects on reducing physical and mental fatigue, visit:

To learn more about Gene-Eden-VIR, and the herpes virus, visit All orders of Gene-Eden-VIR are completely confidential, and no information is shared or sold to any third party. Privacy is assured.


(1) Herpes simplex virus-2 transmission probability estimates based on quantity of viral shedding. Published on March 26, 2014.

(2) Study predicts threshold of viral load for passing herpes from one person to another. Published on March 26, 2014.

(3) Gene-Eden-VIR Is Antiviral: Results of a Post Marketing Clinical Study. Published in September 2013.

(4) Gene-Eden-VIR Decreased Physical and Mental Fatigue in a Post Marketing Clinical Study That Followed FDA Guidelines; Results Support Microcompetition Theory. Published in March, 2014.

polyDNA is a biotechnology company that develops dietary supplements using the unique scientific method developed by Dr. Hanan Polansky, which is based on Computer Intuition.

In addition to his unique scientific method, Dr. Polansky published the highly acclaimed scientific discovery, called Microcompetition with Foreign DNA. The discovery explains how foreign DNA fragments, and specifically, DNA of latent viruses, cause most major diseases.

polyDNA developed Gene-Eden-VIR, an antiviral natural remedy that helps the immune system kill latent viruses.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Mike Davis
+1 5852509999
Email >
Visit website